Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$47.86 - $75.05 $378,094 - $592,895
-7,900 Reduced 13.64%
50,000 $2.71 Million
Q1 2024

May 15, 2024

SELL
$63.75 - $108.06 $7.85 Million - $13.3 Million
-123,200 Reduced 68.03%
57,900 $4.06 Million
Q4 2023

Feb 14, 2024

BUY
$26.88 - $83.49 $4.87 Million - $15.1 Million
181,100 New
181,100 $15.1 Million
Q4 2022

Feb 14, 2023

BUY
$35.77 - $51.11 $894,250 - $1.28 Million
25,000 New
25,000 $1.15 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $5.22B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.